Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
DNA methylation is the major modification of eukaryotic genomes and plays an essential role in mammalian development. Additionally we are shipping and many more products for this protein.
Showing 10 out of 120 products:
Human Polyclonal MBD2 Primary Antibody for EIA, WB - ABIN356599
Zhu, Spitz, Zhang, Grossman, Frazier, Wu: Methyl-CpG-binding domain 2: a protective role in bladder carcinoma. in Cancer 2004
Show all 5 references for ABIN356599
Human Polyclonal MBD2 Primary Antibody for IF, WB - ABIN1881531
Liu, Wu, Chen, Ter-Minassian, Asomaning, Zhai, Wang, Su, Heist, Kulke, Lin, Liu, Christiani: A Large-scale genetic association study of esophageal adenocarcinoma risk. in Carcinogenesis 2010
Show all 3 references for ABIN1881531
Human Polyclonal MBD2 Primary Antibody for WB - ABIN387915
Ghoshal, Majumder, Datta, Motiwala, Bai, Sharma, Frankel, Jacob: Role of human ribosomal RNA (rRNA) promoter methylation and of methyl-CpG-binding protein MBD2 in the suppression of rRNA gene expression. in The Journal of biological chemistry 2004
Show all 2 references for ABIN387915
Human Polyclonal MBD2 Primary Antibody for WB - ABIN2779675
Xing, Stewart, Gu, Lu, Spitz, Wu: Expression of methylation-related genes is associated with overall survival in patients with non-small cell lung cancer. in British journal of cancer 2008
Show all 2 references for ABIN2779675
Human Polyclonal MBD2 Primary Antibody for IHC, ELISA - ABIN334432
Auriol, Billard, Magdinier, Dante: Specific binding of the methyl binding domain protein 2 at the BRCA1-NBR2 locus. in Nucleic acids research 2005
Show all 2 references for ABIN334432
Chicken Polyclonal MBD2 Primary Antibody for WB - ABIN2778640
Le Guezennec, Vermeulen, Brinkman, Hoeijmakers, Cohen, Lasonder, Stunnenberg: MBD2/NuRD and MBD3/NuRD, two distinct complexes with different biochemical and functional properties. in Molecular and cellular biology 2006
Dog (Canine) Polyclonal MBD2 Primary Antibody for EIA, IHC (p) - ABIN375214
Spruijt, Bartels, Brinkman, Tjeertes, Poser, Stunnenberg, Vermeulen: CDK2AP1/DOC-1 is a bona fide subunit of the Mi-2/NuRD complex. in Molecular bioSystems 2010
downregulation of miR (show MLXIP Antibodies)-221 inhibits cell migration and invasion at least partially through targeting MBD2 (show DPEP2 Antibodies) in the human OSCC cell line UM1.
Specifically, methyl-CpG-binding domain protein 2 (MBD2) is revealed to be recruited to DNA damage sites after laser microirradiation, which was mediated through MBD (show DPEP1 Antibodies) domain and MBD2 (show DPEP2 Antibodies) C-terminus.
MBD2 targets short interspersed nuclear elements, but does not exclude RNA Polymerase III.
The dynamics of MBD2 (show DPEP2 Antibodies) deposition across methylated DNA regions was associated with the oncogenic transformation of human mammary cells.
Data suggest that MBD2 (show DPEP2 Antibodies) binds primarily at highly methylated regions, with a strong preference for CpG islands and highlights that MBD2 (show DPEP2 Antibodies) binding sites display increased methylation in primary breast cancer tissues as compared to normal mammary cells.
Biophysical analyses show that the MBD2IDR is an intrinsically disordered region (IDR). However, despite this inherent disorder, MBD2IDR increases the overall binding affinity of MBD2 (show DPEP2 Antibodies) for methylated DNA.
This study investigates the genetic association between methyl-CpG-binding domain (MBD (show DPEP1 Antibodies)) gene polymorphisms and schizophrenia.
The methylated-DNA binding protein (show UBE2V1 Antibodies) MBD2 (show DPEP2 Antibodies) enhances NGFI-A (egr-1 (show EGR1 Antibodies))-mediated transcriptional activation of the glucocorticoid receptor (show NR3C1 Antibodies).
These data point to a potential new approach in targeting the DNA methylation (show HELLS Antibodies) machinery by combination of MBD2 (show DPEP2 Antibodies) and DNMT (show DNMT1 Antibodies) inhibitors.
MBD2 (show DPEP2 Antibodies) seems to play a selective role in gene repression depending on the CpG content of the promoter region
Mbd2 has a key role regulating expression of a range of genes that are associated with optimal dendritic cell activation and function.
methyl-CpG-binding domain protein 2 (MBD2), an epigenetic regulator, controls autoimmunity and EAE through T-bet/Hlx (show HLX Antibodies).
Biophysical analyses show that the MBD2IDR is an intrinsically disordered region (IDR). However, despite this inherent disorder, MBD2IDR increases the overall binding affinity of MBD2 for methylated DNA.
miR (show MLXIP Antibodies)-290/371-Mbd2-Myc (show MYC Antibodies) circuit regulates glycolytic metabolism to promote pluripotency.
these findings suggest that CpG methylation and MBD2 are involved in altering Scn3a (show SCN3A Antibodies) expression during postnatal development and seizure condition.
Data suggest that methyl-CpG binding domain protein 2 (MBD2) gene knockout may lead to accumulation of more deposits on the Bruch's membrane (BM) and influence the pathogenesis of age-related macular degeneration (AMD (show AMD1 Antibodies)).
In metastatic colorectal cancer cells, reduced levels of miR (show MLXIP Antibodies)-221* and miR (show MLXIP Antibodies)-224 increase levels of MBD2, thereby decreasing expression of the metastasis suppressor maspin (show SERPINB5 Antibodies).
Mbd2 has a key role in promoting the Treg-specific demethylation region demethylation, Foxp3 (show FOXP3 Antibodies) expression, and Treg-suppressive function.
Our results strengthen the possibility that MeCP2 (show MECP2 Antibodies) and MBD2 direct interactions could crosslink chromatin fibers and therefore give novel insight into the molecular mechanism of MBD (show DPEP1 Antibodies) mediated global heterochromatin architecture.
DNA methylation is the major modification of eukaryotic genomes and plays an essential role in mammalian development. Human proteins MECP2, MBD1, MBD2, MBD3, and MBD4 comprise a family of nuclear proteins related by the presence in each of a methyl-CpG binding domain (MBD). Each of these proteins, with the exception of MBD3, is capable of binding specifically to methylated DNA. MECP2, MBD1 and MBD2 can also repress transcription from methylated gene promoters. The protein encoded by this gene may function as a mediator of the biological consequences of the methylation signal. It is also reported that the this protein functions as a demethylase to activate transcription, as DNA methylation causes gene silencing. Two transcript variants encoding different isoforms have been found for this gene.
methyl-CpG binding domain protein 2
, methyl-CpG-binding domain protein 2
, methyl-CpG-binding protein MBD2
, methyl-CpG binding protein MBD2